Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients

Clin Immunol. 2019 Jun:203:63-71. doi: 10.1016/j.clim.2019.04.006. Epub 2019 Apr 15.

Abstract

Neuroblastoma is one of the children's malignant tumors with poor prognosis, as well as high recurrence and metastasis rates after surgical removal and chemotherapy. γδ T-cell based immunotherapy receives increasing attention thanks to the strong cytolytic activity to tumor cells. Our previous data revealed a significant increase in circulating γδ T-cell frequency in NB patients. In the present study, we found that beside a reduction of IFN-γ in serum of NB patients, DNAM-1 expression decreased in both circulating and PAM-expanded NB γδ T cells. Upon PAM stimulation, NB γδ T cells showed a reduced level of cell proliferation. In addition, the cytolytic activity of NB γδ T cells to NB cell lines was proved to be attenuated in a co-culture system. The fact that DNAM-1 neutralizing antibody abolished the tumor cell killing accentuates the indispensable role of DNAM-1 molecule in γδ T-cell cytolytic function.

Keywords: Cytolytic activity; DNAM-1; Neuroblastoma; γδ T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / metabolism
  • Antigens, Differentiation, T-Lymphocyte / immunology
  • Antigens, Differentiation, T-Lymphocyte / metabolism*
  • Cancer Vaccines / immunology*
  • Cell Line, Tumor
  • Cell Proliferation
  • Child, Preschool
  • Coculture Techniques
  • Cytotoxicity, Immunologic
  • Down-Regulation
  • Female
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Interferon-gamma / blood
  • Male
  • Neuroblastoma / immunology
  • Neuroblastoma / therapy*
  • Receptors, Antigen, T-Cell, gamma-delta / metabolism
  • T Lineage-Specific Activation Antigen 1
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / transplantation

Substances

  • Antibodies, Neutralizing
  • Antigens, Differentiation, T-Lymphocyte
  • T Lineage-Specific Activation Antigen 1
  • Cancer Vaccines
  • Receptors, Antigen, T-Cell, gamma-delta
  • Interferon-gamma